Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
CDK4/6 Inhibitors in Melanoma: A Comprehensive Review.
Garutti M, Targato G, Buriolla S, Palmero L, Minisini AM, Puglisi F. Garutti M, et al. Among authors: palmero l. Cells. 2021 May 28;10(6):1334. doi: 10.3390/cells10061334. Cells. 2021. PMID: 34071228 Free PMC article. Review.
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives.
de Scordilli M, Michelotti A, Zara D, Palmero L, Alberti M, Noto C, Totaro F, Foltran L, Guardascione M, Iacono D, Ongaro E, Fasola G, Puglisi F. de Scordilli M, et al. Among authors: palmero l. Crit Rev Oncol Hematol. 2023 Jun;186:104013. doi: 10.1016/j.critrevonc.2023.104013. Epub 2023 Apr 26. Crit Rev Oncol Hematol. 2023. PMID: 37116817 Review.
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome.
Michelotti A, de Scordilli M, Palmero L, Guardascione M, Masala M, Roncato R, Foltran L, Ongaro E, Puglisi F. Michelotti A, et al. Among authors: palmero l. Cells. 2021 Aug 9;10(8):2034. doi: 10.3390/cells10082034. Cells. 2021. PMID: 34440803 Free PMC article. Review.
BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis.
Garutti M, Bergnach M, Polesel J, Palmero L, Pizzichetta MA, Puglisi F. Garutti M, et al. Among authors: palmero l. Cancers (Basel). 2022 Dec 26;15(1):141. doi: 10.3390/cancers15010141. Cancers (Basel). 2022. PMID: 36612138 Free PMC article.
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
Bortot L, Targato G, Noto C, Giavarra M, Palmero L, Zara D, Bertoli E, Dri A, Andreetta C, Pascoletti G, Poletto E, Russo S, Seriau L, Mansutti M, Cedolini C, Basile D, Fasola G, Bonotto M, Minisini AM. Bortot L, et al. Among authors: palmero l. Front Oncol. 2022 Jun 7;12:885992. doi: 10.3389/fonc.2022.885992. eCollection 2022. Front Oncol. 2022. PMID: 35747814 Free PMC article.
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer.
Roncato R, Gerratana L, Palmero L, Gagno S, Poetto AS, Peruzzi E, Zanchetta M, Posocco B, De Mattia E, Canil G, Alberti M, Orleni M, Toffoli G, Puglisi F, Cecchin E. Roncato R, et al. Among authors: palmero l. Front Pharmacol. 2022 Jul 22;13:897951. doi: 10.3389/fphar.2022.897951. eCollection 2022. Front Pharmacol. 2022. PMID: 35942220 Free PMC article.
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.
Basile D, Gerratana L, Corvaja C, Pelizzari G, Franceschin G, Bertoli E, Palmero L, Zara D, Alberti M, Buriolla S, Da Ros L, Bonotto M, Mansutti M, Spazzapan S, Cinausero M, Minisini AM, Fasola G, Puglisi F. Basile D, et al. Among authors: palmero l. Breast. 2021 Jun;57:104-112. doi: 10.1016/j.breast.2021.02.015. Epub 2021 Mar 12. Breast. 2021. PMID: 33812267 Free PMC article.